Business Description
Burzynski Research Institute Inc
NAICS : 325412
SIC : 2834
ISIN : US1231591058
Description
Burzynski Research Institute Inc operates primarily as a research and development facility of Antineoplaston drugs currently being tested for the use in the treatment of cancer, and provides consulting services.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | -12.5 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year FCF Growth Rate | -10.1 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 38.47 | |||||
9-Day RSI | 44.27 | |||||
14-Day RSI | 46.46 | |||||
6-1 Month Momentum % | -2.27 | |||||
12-1 Month Momentum % | -49.41 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.07 | |||||
Quick Ratio | 0.07 | |||||
Cash Ratio | 0.04 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -1.23 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -83437.5 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -3.94 | |||||
EV-to-EBITDA | -3.94 | |||||
EV-to-FCF | -10.04 | |||||
Earnings Yield (Greenblatt) % | -25.38 | |||||
FCF Yield % | -9.95 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BZYR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Burzynski Research Institute Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.007 | ||
Beta | 0.27 | ||
Volatility % | 88.1 | ||
14-Day RSI | 46.46 | ||
14-Day ATR ($) | 0.002846 | ||
20-Day SMA ($) | 0.042265 | ||
12-1 Month Momentum % | -49.41 | ||
52-Week Range ($) | 0.013 - 0.085 | ||
Shares Outstanding (Mil) | 131.45 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Burzynski Research Institute Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Burzynski Research Institute Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Burzynski Research Institute Inc Frequently Asked Questions
What is Burzynski Research Institute Inc(BZYR)'s stock price today?
The current price of BZYR is $0.04. The 52 week high of BZYR is $0.09 and 52 week low is $0.01.
When is next earnings date of Burzynski Research Institute Inc(BZYR)?
The next earnings date of Burzynski Research Institute Inc(BZYR) is .
Does Burzynski Research Institute Inc(BZYR) pay dividends? If so, how much?
Burzynski Research Institute Inc(BZYR) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |